Protective effect of copper against pancreatic insult in streptozotocin-induced diabetogenic rat

[1]  S. Liochev,et al.  Copper increases superoxide dismutase activity in rat liver. , 1984, Archives of biochemistry and biophysics.

[2]  E. Wiener.  The role of oxygen-free radicals in human disease process , 1984 .

[3]  B. Halliwell,et al.  LIPID PEROXIDATION, OXYGEN RADICALS, CELL DAMAGE, AND ANTIOXIDANT THERAPY , 1984, The Lancet.

[4]  K. Simmons.  Defense against free radicals has therapeutic implications. , 1984, Journal of the American Medical Association (JAMA).

[5]  Bulkley Gb.  The role of oxygen free radicals in human disease processes. , 1983 .

[6]  J. Doroshow.  Effect of anthracycline antibiotics on oxygen radical formation in rat heart. , 1983, Cancer research.

[7]  M. Buse,et al.  Protective role of superoxide dismutase against diabetogenic drugs. , 1982, The Journal of clinical investigation.

[8]  D. Winge,et al.  Rat liver Cu,Zn-superoxide dismutase. Subcellular location in lysosomes. , 1982, The Journal of biological chemistry.

[9]  M. Buse,et al.  Superoxide dismutase in human islets of Langerhans. , 1981, New England Journal of Medicine.

[10]  M. Buse,et al.  The Inhibition of Islet Superoxide Dismutase by Diabetogenic Drugs , 1981, Diabetes.

[11]  L. J. Fischer,et al.  Inhibition of Alloxan Action in Isolated Pancreatic Islets by Superoxide Dismutase, Catalase, and a Metal Chelator , 1980, Diabetes.

[12]  J. Crapo,et al.  Isolation and characterization of a manganese-containing superoxide dismutase from rat liver. , 1978, Archives of biochemistry and biophysics.

[13]  I. Fridovich,et al.  Isolation and characterization of a manganese-containing superoxide dismutase from yeast. , 1975, The Journal of biological chemistry.

[14]  I. Fridovich,et al.  Superoxide dismutase. Organelle specificity. , 1973, The Journal of biological chemistry.

[15]  F. Stirpe,et al.  The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. , 1972, The Biochemical journal.

[16]  C. Rerup.  Drugs producing diabetes through damage of the insulin secreting cells. , 1970, Pharmacological reviews.

[17]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[18]  I. Fridovich,et al.  The reduction of cytochrome c by milk xanthine oxidase. , 1968, The Journal of biological chemistry.

[19]  N. Rakieten,et al.  Studies on the diabetogenic action of streptozotocin (NSC-37917). , 1963, Cancer chemotherapy reports.

[20]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[21]  H. Kolb,et al.  Diabetogenic action of streptozotocin: essential role of membrane permeability. , 1987, Acta endocrinologica.

[22]  P. Bora,et al.  Diabetogenic action of streptozotocin , 1982 .

[23]  D. Winge,et al.  Rat Liver Cu,Zn-Superoxide Dismutase , 1982 .

[24]  J. Doroshow,et al.  Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. , 1980, The Journal of clinical investigation.

[25]  N. Rakieten.  Studies on the diabetogenic action of streptozotocin , 1963 .